trending Market Intelligence /marketintelligence/en/news-insights/trending/2yzaq2t9yd_vntdoqyktta2 content esgSubNav
In This List

Avid Bioservices CFO resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Avid Bioservices CFO resigns

Paul Lytle is voluntarily resigning as CFO of Avid Bioservices Inc.

Lytle's resignation will be effective 90 days from the date of his Feb. 23 notice.

The company is starting a search for its next CFO.

Avid Bioservices is a Tustin, Calif.-based a biopharmaceutical company that researches and develops antibodies for the treatment of cancer in the U.S.